Article
Antibody effector functions critical to mucosal protection against HIV-1
2017-01-01
Abstract excerpt
Human Immunodeficiency Virus-1 (HIV-1) is a retrovirus that was identified more than thirty years ago as the cause of Acquired Immunodeficiency Syndrome (AIDS). The only HIV-1 vaccine trial to demonstrate any potential, the Thai RV144 HIV-1 vaccine trial, was correlated with antibody-dependent cellular cytotoxicity (ADCC) mediated by non-neutralising antibodies (nnAb). This has led to speculation that ADCC and oth...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- 3b3dcd17-a511-5087-a956-d5bdd7a88a37
- DOI
- 10.25560/67637
